MX2013009842A - Composicion que comprende receptor gamma activado por proliferador de peroxisoma. - Google Patents

Composicion que comprende receptor gamma activado por proliferador de peroxisoma.

Info

Publication number
MX2013009842A
MX2013009842A MX2013009842A MX2013009842A MX2013009842A MX 2013009842 A MX2013009842 A MX 2013009842A MX 2013009842 A MX2013009842 A MX 2013009842A MX 2013009842 A MX2013009842 A MX 2013009842A MX 2013009842 A MX2013009842 A MX 2013009842A
Authority
MX
Mexico
Prior art keywords
composition
gamma
activated receptor
peroxisome proliferator
ppar
Prior art date
Application number
MX2013009842A
Other languages
English (en)
Inventor
Rainer Pooth
Heiko Barg
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of MX2013009842A publication Critical patent/MX2013009842A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/86—Products or compounds obtained by genetic engineering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Una composición inyectable que comprende receptor gamma activado por proliferador de peroxisoma para administración subcutánea y un método para mejorar imperfecciones de la piel, en donde la composición inyectable es administrada subcutáneamente en el área de las imperfecciones de la piel que comprende los pasos de: a) identificar un área de imperfecciones de la piel, b) administrar una cantidad segura y cosméticamente efectiva de la composición de manera subcutánea al área de las imperfecciones de la piel.
MX2013009842A 2011-03-01 2012-02-29 Composicion que comprende receptor gamma activado por proliferador de peroxisoma. MX2013009842A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161447726P 2011-03-01 2011-03-01
EP11156450 2011-03-01
PCT/EP2012/053414 WO2012117013A1 (en) 2011-03-01 2012-02-29 Composition comprising peroxisome proliferator-activated receptor-gamma (ppar)

Publications (1)

Publication Number Publication Date
MX2013009842A true MX2013009842A (es) 2014-03-12

Family

ID=44260780

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013009842A MX2013009842A (es) 2011-03-01 2012-02-29 Composicion que comprende receptor gamma activado por proliferador de peroxisoma.

Country Status (12)

Country Link
US (1) US20130331332A1 (es)
EP (1) EP2680809A1 (es)
JP (1) JP2014509324A (es)
KR (1) KR20140027943A (es)
CN (1) CN103442676A (es)
AU (1) AU2012222380A1 (es)
BR (1) BR112013022085A2 (es)
CA (1) CA2825568A1 (es)
MX (1) MX2013009842A (es)
RU (1) RU2013142169A (es)
WO (1) WO2012117013A1 (es)
ZA (1) ZA201305811B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140147950A (ko) * 2013-06-20 2014-12-31 서울대학교산학협력단 필러와 보틀리눔 독소를 포함하는 피부 주름, 노화 개선 또는 신경근육 관련 질환 치료용 조성물
US9687455B2 (en) 2014-08-14 2017-06-27 John Daniel Dobak Sodium tetradecyl sulfate formulations for treatment of adipose tissue
FR3029787B1 (fr) * 2014-12-10 2019-11-29 L'oreal Composition nettoyante a base a base d'un polyethylenegycol, d'un polyether ester et d'un agent de suspension polymerique
US9351945B1 (en) 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
US11622929B2 (en) 2016-03-08 2023-04-11 Living Proof, Inc. Long lasting cosmetic compositions
WO2019055445A2 (en) 2017-09-13 2019-03-21 Living Proof, Inc. COLOR PROTECTION COMPOSITIONS
CN111133023B (zh) 2017-09-13 2022-10-18 生活实验公司 持久化妆品组合物
CN109568567A (zh) * 2019-01-15 2019-04-05 武汉德丽福生物科技有限公司 一种微针减肥贴片及其制备方法
CN109925501A (zh) * 2019-04-26 2019-06-25 贝亲母婴用品（上海）有限公司 一种用于改善皮肤屏障的组合物
WO2021052370A1 (en) * 2019-09-16 2021-03-25 Institute Of Zoology, Chinese Academy Of Sciences Methods and compositions for tissue regeneration

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436993B1 (en) * 1999-07-13 2002-08-20 The Salk Institute For Biological Studies Use of RAR antagonists as modulators of hormone mediated processes
US20040152746A1 (en) * 2001-04-30 2004-08-05 Bardsley Hazel Judith Treatment of scarring and related conditions using ppar-gamma activators
US20040101959A1 (en) * 2002-11-21 2004-05-27 Olga Marko Treatment of tissue with undifferentiated mesenchymal cells
FR2862870A1 (fr) * 2003-12-01 2005-06-03 Galderma Res & Dev Utilisation d'activateurs de recepteurs ppar en cosmetique et dermatologie.
NZ566083A (en) * 2005-08-29 2012-11-30 Healor Ltd Methods and compositions for prevention and treatment of diabetic and aged skin
FR2904549B1 (fr) * 2006-08-03 2012-12-14 Sederma Sa Composition comprenant de la sarsasapogenine
US20090291986A1 (en) * 2008-05-22 2009-11-26 Apostolos Pappas Composition and method of treating facial skin defect
TW201103572A (en) * 2009-05-04 2011-02-01 Neostem Inc Method and composition for restoration of age-related tissue loss in the face or selected areas of the body

Also Published As

Publication number Publication date
CA2825568A1 (en) 2012-09-07
WO2012117013A1 (en) 2012-09-07
AU2012222380A1 (en) 2013-08-22
ZA201305811B (en) 2014-04-30
CN103442676A (zh) 2013-12-11
BR112013022085A2 (pt) 2016-08-09
RU2013142169A (ru) 2015-04-10
JP2014509324A (ja) 2014-04-17
US20130331332A1 (en) 2013-12-12
EP2680809A1 (en) 2014-01-08
KR20140027943A (ko) 2014-03-07

Similar Documents

Publication Publication Date Title
MX2013009842A (es) Composicion que comprende receptor gamma activado por proliferador de peroxisoma.
IN2014KN00996A (es)
MX2013004406A (es) Tratamiento de diabetes mellitus usando inyecciones de insulina administradas con intervalos variables de inyeccion.
EA201400030A1 (ru) Способ непрерывного подкожного введения инсулина с использованием фермента, разрушающего хиалуронан
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
NZ710157A (en) Use of guanethidine for treating hypertension by local vascular delivery
EA201500019A1 (ru) Способ лечения gd2-положительного рака
WO2012023623A3 (ja) ハンター症候群の治療剤
MY192033A (en) Method of dosing and use of soft anticholinergic esters
EP2702994A3 (en) Methods of administering pirfenidone therapy
SA515370012B1 (ar) علاج السرطان باستخدام مركبات داي هيدرو بيرازينو ــ بيرازين
MX366076B (es) Vitamina d3 y analogos de la misma para tratar alopecia.
WO2013028818A8 (en) Pyrimido- pyridazinone compounds and use thereof
MX2021002513A (es) Composicion que comprende desintegrina y metaloproteinasa con motivos tipo i de trombospondina 13 (adamts13) para administracion subcutanea.
IN2014DN09383A (es)
EA201170970A1 (ru) Применение деферипрона для лечения и предупреждения заболеваний глаз, связанных с железом
WO2014018763A3 (en) Method of treating type i diabetes using apolipoprotein aiv
EA201690903A1 (ru) Лечение глаукомы с использованием лаквинимода
EP2606885A4 (en) "RENESSANS" MEDICINAL PREPARATION WITH ANTIBACTERIAL, ANTI-ULCER AND IMMUNOMODULATORY ACTION
UA79795U (ru) Способ лечения остеоартропатий у больных сахарным диабетом
UA69525U (ru) Способ лечения больных деформирующими артрозами суставов
EA032959B1 (ru) Применение бремеланотида в терапии женской сексуальной дисфункции
WO2012075211A3 (en) Combination therapy with a gallium complex
MD520Y (en) Method for postoperative treatment of patients with nephrolithiasis
UA69690U (ru) Способ лечения больных с синдромом повышенной утомляемости на фоне хронической тонзиллярной инфекции

Legal Events

Date Code Title Description
FA Abandonment or withdrawal